Boehringer Ingelheim Vetmedica Gmbh

Other

Brian Thomas Martinson

Dianna M Murphy Jordan

Arun V Iyer

Christine Margaret Muehlenthaler

Axel Neubauer

Dianna M Jordan

Eric Martin Vaughn

Michael B Roof

Joseph Gilbert Victoria

The present invention relates to an immunogenic composition comprising: a) one or more antigen ofand one or more antigens ofand b) a pharmaceutically acceptable carrier. Furthermore, the present invention relates to an immunogenic composition that comprises a) one or more mycoplasma antigens of mycoplasma bacteria selected from the group consisting ofandand b) one or more components of a eukaryotic cell system. Moreover, the present invention also provides an immunogenic composition obtained by a method comprising a) cultivation of a mycoplasma bacteria selected from the group consisting ofandin a serum-reduced, eukaryotic cell system; b) obtaining an antigen of such mycoplasma bacteria; and c) addition of a pharmaceutically acceptable carrier.

Immunogenic composition comprising mycoplasma antigens

The present invention relates to a method for the preparation of an immunogenic composition for the treatment and/or prophylaxis of mycoplasma infections in a subject comprising the cultivation of mycoplasma bacteria in a serum-reduced or swine serum-free, eukaryotic cell system; obtaining an antigen of the mycoplasma bacteria; and addition of a pharmaceutically acceptable carrier. Further, the present invention relates to the immunogenic composition obtainable by said method and a method for immunizing a subject comprising the administration of said immunogenic composition to a subject.

Method of making a mycoplasma vaccine

The present invention relates to an immunogenic composition comprising: a) one or more antigen ofand one or more antigens of; and b) a pharmaceutically acceptable carrier. Furthermore, the present invention relates to an immunogenic composition that comprises a) one or moreantigens ofbacteria selected from the group consisting ofand; and b) one or more components of a eukaryotic cell system. Moreover, the present invention also provides an immunogenic composition obtained by a method comprising a) cultivation of abacteria selected from the group consisting ofandin a serum-reduced, eukaryotic cell system; b) obtaining an antigen of suchbacteria; and c) addition of a pharmaceutically acceptable carrier.

The present invention relates to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) mutant strains having increased stability; compositions containing the strains or antigens derived therefrom; vaccines containing the strains, including killed, attenuated or subunit vaccines; nucleic acids encoding PRRSV polypeptides, polypeptides encoded by the nucleic acids, including antigenic fragments thereof; antibodies which specifically bind to said polypeptides, and methods making and using thereof.

Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use

The present invention relates to a method for the preparation of an immunogenic composition for the treatment and/or prophylaxis ofinfections in a subject comprising the cultivation ofbacteria in a serum-reduced or swine serum-free, eukaryotic cell system; obtaining an antigen of thebacteria; and addition of a pharmaceutically acceptable carrier. Further, the present invention relates to the immunogenic composition obtainable by said method and a method for immunizing a subject comprising the administration of said immunogenic composition to a subject.

Growing community of inventors

Duncombe, IA, United States of America

Brian Thomas Martinson